Physician profile
Jenna Studer
NPI 1790139418
$1,358.44
in general payments reported to CMS, 2019-2025
22 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $41.10 · 2021: $288 · 2022: $293 · 2023: $331 · 2024: $191 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $173.34 | 2023-2024 | Myfembree |
| Abbvie INC. | $172.31 | 2020-2025 | Lo Loestrin Fe |
| Myovant Sciences INC. | $170.41 | 2021-2022 | |
| Biogen, INC. | $134.18 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $111.64 | 2023-2025 | Veozah |
| Pfizer INC. | $96.82 | 2022-2025 | |
| Hologic Sales and Service, LLC | $67.45 | 2021-2023 | Aptima |
| Organon LLC | $53.92 | 2022-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $53.08 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $51.75 | 2021-2024 | |
| Exeltis, USA INC. | $41.52 | 2022 | |
| Therapeuticsmd, INC. | $35.06 | 2021-2022 | |
| Agile Therapeutics, INC. | $30.30 | 2021 | |
| Merck Sharp & Dohme LLC | $30.23 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $22.87 | 2024 | Exparel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $22.20 | 2023 | Balcoltra |
| Daiichi Sankyo INC. | $18.93 | 2021 | |
| Smith+Nephew, INC. | $18.07 | 2025 | Pico 7, "Acticoat 4"" X 4""" |
| Gynesonics, INC. | $14.57 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $13.72 | 2021 | |
| Boston Scientific Corporation | $13.61 | 2021 | |
| Evofem Biosciences, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Studer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.